IL4R and neoplasm: These results along with our immunohistology findings of excised tumor tissues further demonstrated targeting ELPs can deliver siRNA more specifically to tumors highly expressing IL-4R by protecting payloads, traversing membrane barriers, and releasing their contents to silence target genes.